IceCure Medical's (ICCM) Buy Rating Reaffirmed at HC Wainwright

IceCure Medical (NASDAQ:ICCM – Get Rating)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a report issued on Tuesday, Benzinga reports. They presently have a $3.00 price target on the stock. HC Wainwright’s price objective would suggest a potential upside of 158.60% from the company’s previous close. IceCure Medical […]

Related Keywords

United States ,Israel ,America , ,Icecure Medical Company Profile ,Icecure Medical Ltd ,America Corp ,Boothbay Fund Management ,Jpmorgan Chase Co ,Icecure Medical ,Get Rating ,Cure Medical Trading Down ,Cure Medical ,Fund Management ,Cure Medical Ltd ,Icecure Medical Daily ,Nasdaq Iccm ,Iccm ,Medical ,Reiterated Rating ,Hc Wainwright ,